查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2146291

精準發酵CDMO服務市場展望、成長要素及機會（2026-2033年）

Precision Fermentation CDMO Services Market Outlook, Growth Drivers and Opportunities, 2026-2033
出版日期: | 出版商: Fairfield Market Research | 英文 195 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計到 2033 年，精細發酵 CDMO 服務市場規模將達到 79.3 億美元。

介紹

全球精準發酵CDMO服務市場預計在2026年達到18億美元，並在2026年至2033年間以23.6%的複合年成長率成長，到2033年達到79.3億美元。 Fairfield Market Research透過已發布的市場區隔數據（包括產品、客戶和區域細分）對該市場進行了分析。該預測為評估整個研究期間的商業優先事項提供了一個通用標準。

市場洞察

依服務類型分類，包括菌株開發與最佳化、製程放大與生產、下游加工與純化等。按最終用戶分類，包括替代蛋白公司、製藥和生物技術公司等。依發酵類型分類，包括微生物發酵和細胞培養發酵。這些分類有助於企業評估哪些服務和客戶需求屬於市場範圍。請結合全球預測參考這些細分定義，而不是將其統一應用於所有類別。

本報告將服務類型分類中的「菌株開發與最佳化」與「製程放大與生產」作為兩個獨立的類別。明確區分這些類別有助於讀者在將整體市場預測應用於具體產業計畫之前，更輕鬆地評估所提供服務的適用性。

在本報告中，我們將「替代蛋白公司」和「製藥及生技公司」作為最終用戶分類中的兩個獨立類別。明確區分這些類別有助於讀者在將整體市場預測應用於具體產業計畫之前，更輕鬆地評估其產品和服務是否適合目標市場。

本報告在對發酵類型進行分類時，將「微生物發酵」和「細胞培養發酵」視為兩個獨立的類別。明確區分這些類別有助於讀者在將整體市場預測應用於具體產業計畫之前，更輕鬆地評估其產品和服務的適用性。

促進因素

Fairfield 的成長分析涵蓋蛋白質、生物技術和製造業。這些主題是評估需求格局和供應商面臨的挑戰的起點。它們的商業性重要性因目標細分市場、客戶和地區而異。企業可以利用本報告中的詳細洞察，將這些需求促進因素與其產品組合和銷售重點連結起來。

商業機會

商業機會分析著重於蛋白質和成本。考慮業務擴張的公司可以將這些方面與自身現有能力、市場策略和客戶需求進行比較。細分市場選擇和區域定位仍然是評估已發布預測對特定業務相關性的關鍵因素。

考慮「菌株開發與最佳化」的公司可以將客戶需求與「製程放大與生產製造」相關的需求進行比較。這種比較有助於確定更聚焦的產品組合，識別合適的目標市場，並在分配資源前確定還需要哪些針對特定領域的額外支援。

考慮開發替代蛋白產品的公司可以將自身客戶需求與製藥和生技公司的客戶需求進行比較。這種比較有助於制定更精準的產品組合，確定合適的目標市場，並在分配資源之前明確特定細分市場還需要哪些額外證據。

區域分析

費爾菲爾德的區域分析指出，北美是主要市場。地理範圍涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。在進行區域間比較時，請使用本報告中特有的市場定義和預測期。

目錄

第1章：摘要整理

第2章 市場概覽

  • 市場定義與細分
  • 市場動態
    • 主要成長要素
    • 主要阻礙因素
    • 市場機遇

第3章：2026-2033年全球精準發酵CDMO服務市場展望

  • 全球精準發酵CDMO服務市場展望（依服務類型分類，價值：10億美元），2026-2033年
    • 菌株開發與最佳化
    • 工藝放大和生產
    • 下游工藝和精煉
    • 其他
  • 全球精準發酵CDMO服務市場展望（以最終用戶分類，價值：10億美元），2026-2033年
    • 替代蛋白公司
    • 製藥和生物技術公司
    • 其他
  • 全球精準發酵CDMO服務市場展望（依發酵類型分類，價值：10億美元），2026-2033年
    • 微生物發酵
    • 基於細胞培養的發酵
  • 全球精準發酵CDMO服務市場區域及市場規模展望（2026-2033年）
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第4章：北美精準發酵CDMO服務市場展望：2026-2033年

  • 北美：按服務類型分類的市場規模，2026-2033 年
    • 菌株開發與最佳化
    • 工藝放大和生產
    • 下游工藝和精煉
    • 其他
  • 北美：按最終用戶分類的市場規模，2026-2033 年
    • 替代蛋白公司
    • 製藥和生物技術公司
    • 其他
  • 北美：按發酵類型分類的市場規模，2026-2033 年
    • 微生物發酵
    • 基於細胞培養的發酵
  • 北美：按國家和地區分類的市場規模，2026-2033年
    • 美國
    • 加拿大

第5章：歐洲精準發酵CDMO服務市場展望：2026-2033年

  • 歐洲：依服務類型分類的市場規模，2026-2033年
    • 菌株開發與最佳化
    • 工藝放大和生產
    • 下游工藝和精煉
    • 其他
  • 歐洲：以最終用戶分類的市場規模，2026-2033 年
    • 替代蛋白公司
    • 製藥和生物技術公司
    • 其他
  • 歐洲：按發酵類型分類的市場規模，2026-2033 年
    • 微生物發酵
    • 基於細胞培養的發酵

第6章：亞太地區精細發酵CDMO服務市場展望：2026-2033年

  • 亞太地區：依服務類型分類的市場規模，2026-2033年
    • 菌株開發與最佳化
    • 工藝放大和生產
    • 下游工藝和精煉
    • 其他
  • 亞太地區：依最終用戶分類的市場規模，2026-2033年
    • 替代蛋白公司
    • 製藥和生物技術公司
    • 其他
  • 亞太地區：依發酵類型分類的市場規模，2026-2033年
    • 微生物發酵
    • 基於細胞培養的發酵
  • 亞太地區：按國家和次區域分類的市場規模，2026-2033年
    • 中國
    • 日本
    • 韓國

第7章：拉丁美洲精細發酵CDMO服務市場展望：2026-2033年

  • 拉丁美洲：按服務類型分類的市場規模，2026-2033 年
    • 菌株開發與最佳化
    • 工藝放大和生產
    • 下游工藝和精煉
    • 其他
  • 拉丁美洲：按最終用戶分類的市場規模，2026-2033 年
    • 替代蛋白公司
    • 製藥和生物技術公司
    • 其他
  • 拉丁美洲：按發酵類型分類的市場規模，2026-2033年
    • 微生物發酵
    • 基於細胞培養的發酵
  • 拉丁美洲：按國家和地區分類的市場規模，2026-2033年
    • 巴西
    • 墨西哥

第8章：中東與非洲精細發酵CDMO服務市場展望：2026-2033年

  • 中東和非洲：按服務類型分類的市場規模，2026-2033年
    • 菌株開發與最佳化
    • 工藝放大和生產
    • 下游工藝和精煉
    • 其他
  • 中東和非洲：按最終用戶分類的市場規模，2026-2033 年
    • 替代蛋白公司
    • 製藥和生物技術公司
    • 其他
  • 中東和非洲：按發酵類型分類的市場規模，2026-2033 年
    • 微生物發酵
    • 基於細胞培養的發酵

第9章 競爭情勢

  • 競爭定位與差異化
  • 公司簡介
    • Cargill, Incorporated
    • Ginkgo Bioworks Holdings, Inc.
    • Lonza Group AG
    • Archer-Daniels-Midland Company
    • Amyris, Inc.
    • Liberation Labs, Inc.
    • EnginZyme AB
    • ABEC, Inc.
    • Fermbox Bio Private Limited
    • Arzeda Corp.

第10章附錄

簡介目錄

Precision Fermentation CDMO Services Market Projected to Reach US$7.93 Bn by 2033

Introduction

The global precision fermentation cdmo services market is valued at US$1.8 Bn in 2026 and projected to reach US$7.93 Bn by 2033, at a CAGR of 23.6% during 2026-2033. Fairfield Market Research assesses the market through its published product, customer and geographical classifications. The forecast provides a common basis for evaluating commercial priorities across the study period.

Market Insights

The service type breakdown covers Strain Development & Optimization, Process Scale-Up & Manufacturing, Downstream Processing & Purification and Others. The end user breakdown covers Alternative Protein Companies, Pharmaceutical & Biotech Companies and Others. The fermentation type breakdown covers Microbial Fermentation and Cell Culture-based Fermentation. These distinctions help businesses assess which offerings and customer requirements fall within the market's scope. The global forecast should be read alongside these segment definitions rather than applied uniformly to every individual category.

Within the service type classification, Strain Development & Optimization and Process Scale-Up & Manufacturing represent separate categories in the report. Keeping these categories distinct helps readers evaluate the fit of an offering before applying the overall market forecast to a specific commercial plan.

Within the end user classification, Alternative Protein Companies and Pharmaceutical & Biotech Companies represent separate categories in the report. Keeping these categories distinct helps readers evaluate the fit of an offering before applying the overall market forecast to a specific commercial plan.

Within the fermentation type classification, Microbial Fermentation and Cell Culture-based Fermentation represent separate categories in the report. Keeping these categories distinct helps readers evaluate the fit of an offering before applying the overall market forecast to a specific commercial plan.

Drivers

Fairfield's growth discussion addresses protein, biotechnology and manufacturing. These themes provide a starting point for assessing demand conditions and the requirements facing suppliers. Their commercial importance depends on the segment, customer and region concerned. Businesses can use the report's detailed discussion to connect these demand factors with their own portfolios and sales priorities.

Business Opportunity

The opportunity discussion highlights protein and cost. Companies evaluating expansion can compare these areas with their existing capabilities, route to market and customer needs. Segment selection and regional positioning remain central to assessing the relevance of the published forecast to an individual business.

Businesses considering Strain Development & Optimization can compare its customer requirements with those associated with Process Scale-Up & Manufacturing. This comparison can help define a more focused portfolio, identify the appropriate sales audience and establish which questions require additional segment evidence before resources are committed.

Businesses considering Alternative Protein Companies can compare its customer requirements with those associated with Pharmaceutical & Biotech Companies. This comparison can help define a more focused portfolio, identify the appropriate sales audience and establish which questions require additional segment evidence before resources are committed.

Region Analysis

North America is identified in Fairfield's regional analysis as a leading market. The geographical scope covers North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Regional comparisons should use the report's own market definitions and forecast period.

Key Players

  • Cargill, Incorporated
  • Ginkgo Bioworks Holdings, Inc.
  • Lonza Group AG
  • Archer-Daniels-Midland Company
  • Amyris, Inc.
  • Liberation Labs, Inc.
  • EnginZyme AB
  • ABEC, Inc.
  • Fermbox Bio Private Limited
  • Arzeda Corp.

Segmentation

By Service Type

  • Strain Development & Optimization
  • Process Scale-Up & Manufacturing
  • Downstream Processing & Purification
  • Others

By End User

  • Alternative Protein Companies
  • Pharmaceutical & Biotech Companies
  • Others

By Fermentation Type

  • Microbial Fermentation
  • Cell Culture-based Fermentation

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Precision Fermentation CDMO Services Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Highlights
  • 1.4. Regional Snapshot by Value 2026

2. Market Overview

  • 2.1. Market Definition and Segmentation
  • 2.2. Market Dynamics
    • 2.2.1. Key Growth Drivers
    • 2.2.2. Key Restraints
    • 2.2.3. Market Opportunities

3. Global Precision Fermentation CDMO Services Market Outlook 2026-2033

  • 3.1. Global Precision Fermentation CDMO Services Market Outlook, by Service Type, Value (USD Billion), 2026-2033
    • 3.1.1. Strain Development & Optimization
    • 3.1.2. Process Scale-Up & Manufacturing
    • 3.1.3. Downstream Processing & Purification
    • 3.1.4. Others
  • 3.2. Global Precision Fermentation CDMO Services Market Outlook, by End User, Value (USD Billion), 2026-2033
    • 3.2.1. Alternative Protein Companies
    • 3.2.2. Pharmaceutical & Biotech Companies
    • 3.2.3. Others
  • 3.3. Global Precision Fermentation CDMO Services Market Outlook, by Fermentation Type, Value (USD Billion), 2026-2033
    • 3.3.1. Microbial Fermentation
    • 3.3.2. Cell Culture-based Fermentation
  • 3.4. Global Precision Fermentation CDMO Services Market Outlook, by Region, Value (USD Billion), 2026-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Precision Fermentation CDMO Services Market Outlook 2026-2033

  • 4.1. North America Precision Fermentation CDMO Services Market Outlook, by Service Type, Value (USD Billion), 2026-2033
    • 4.1.1. Strain Development & Optimization
    • 4.1.2. Process Scale-Up & Manufacturing
    • 4.1.3. Downstream Processing & Purification
    • 4.1.4. Others
  • 4.2. North America Precision Fermentation CDMO Services Market Outlook, by End User, Value (USD Billion), 2026-2033
    • 4.2.1. Alternative Protein Companies
    • 4.2.2. Pharmaceutical & Biotech Companies
    • 4.2.3. Others
  • 4.3. North America Precision Fermentation CDMO Services Market Outlook, by Fermentation Type, Value (USD Billion), 2026-2033
    • 4.3.1. Microbial Fermentation
    • 4.3.2. Cell Culture-based Fermentation
  • 4.4. North America Precision Fermentation CDMO Services Market Outlook, by Country and Subregion, Value (USD Billion), 2026-2033
    • 4.4.1. United States Precision Fermentation CDMO Services Market Outlook, by Service Type, 2026-2033
    • 4.4.2. United States Precision Fermentation CDMO Services Market Outlook, by End User, 2026-2033
    • 4.4.3. United States Precision Fermentation CDMO Services Market Outlook, by Fermentation Type, 2026-2033
    • 4.4.4. Canada Precision Fermentation CDMO Services Market Outlook, by Service Type, 2026-2033
    • 4.4.5. Canada Precision Fermentation CDMO Services Market Outlook, by End User, 2026-2033
    • 4.4.6. Canada Precision Fermentation CDMO Services Market Outlook, by Fermentation Type, 2026-2033

5. Europe Precision Fermentation CDMO Services Market Outlook 2026-2033

  • 5.1. Europe Precision Fermentation CDMO Services Market Outlook, by Service Type, Value (USD Billion), 2026-2033
    • 5.1.1. Strain Development & Optimization
    • 5.1.2. Process Scale-Up & Manufacturing
    • 5.1.3. Downstream Processing & Purification
    • 5.1.4. Others
  • 5.2. Europe Precision Fermentation CDMO Services Market Outlook, by End User, Value (USD Billion), 2026-2033
    • 5.2.1. Alternative Protein Companies
    • 5.2.2. Pharmaceutical & Biotech Companies
    • 5.2.3. Others
  • 5.3. Europe Precision Fermentation CDMO Services Market Outlook, by Fermentation Type, Value (USD Billion), 2026-2033
    • 5.3.1. Microbial Fermentation
    • 5.3.2. Cell Culture-based Fermentation

6. Asia Pacific Precision Fermentation CDMO Services Market Outlook 2026-2033

  • 6.1. Asia Pacific Precision Fermentation CDMO Services Market Outlook, by Service Type, Value (USD Billion), 2026-2033
    • 6.1.1. Strain Development & Optimization
    • 6.1.2. Process Scale-Up & Manufacturing
    • 6.1.3. Downstream Processing & Purification
    • 6.1.4. Others
  • 6.2. Asia Pacific Precision Fermentation CDMO Services Market Outlook, by End User, Value (USD Billion), 2026-2033
    • 6.2.1. Alternative Protein Companies
    • 6.2.2. Pharmaceutical & Biotech Companies
    • 6.2.3. Others
  • 6.3. Asia Pacific Precision Fermentation CDMO Services Market Outlook, by Fermentation Type, Value (USD Billion), 2026-2033
    • 6.3.1. Microbial Fermentation
    • 6.3.2. Cell Culture-based Fermentation
  • 6.4. Asia Pacific Precision Fermentation CDMO Services Market Outlook, by Country and Subregion, Value (USD Billion), 2026-2033
    • 6.4.1. China Precision Fermentation CDMO Services Market Outlook, by Service Type, 2026-2033
    • 6.4.2. China Precision Fermentation CDMO Services Market Outlook, by End User, 2026-2033
    • 6.4.3. China Precision Fermentation CDMO Services Market Outlook, by Fermentation Type, 2026-2033
    • 6.4.4. Japan Precision Fermentation CDMO Services Market Outlook, by Service Type, 2026-2033
    • 6.4.5. Japan Precision Fermentation CDMO Services Market Outlook, by End User, 2026-2033
    • 6.4.6. Japan Precision Fermentation CDMO Services Market Outlook, by Fermentation Type, 2026-2033
    • 6.4.7. South Korea Precision Fermentation CDMO Services Market Outlook, by Service Type, 2026-2033
    • 6.4.8. South Korea Precision Fermentation CDMO Services Market Outlook, by End User, 2026-2033
    • 6.4.9. South Korea Precision Fermentation CDMO Services Market Outlook, by Fermentation Type, 2026-2033

7. Latin America Precision Fermentation CDMO Services Market Outlook 2026-2033

  • 7.1. Latin America Precision Fermentation CDMO Services Market Outlook, by Service Type, Value (USD Billion), 2026-2033
    • 7.1.1. Strain Development & Optimization
    • 7.1.2. Process Scale-Up & Manufacturing
    • 7.1.3. Downstream Processing & Purification
    • 7.1.4. Others
  • 7.2. Latin America Precision Fermentation CDMO Services Market Outlook, by End User, Value (USD Billion), 2026-2033
    • 7.2.1. Alternative Protein Companies
    • 7.2.2. Pharmaceutical & Biotech Companies
    • 7.2.3. Others
  • 7.3. Latin America Precision Fermentation CDMO Services Market Outlook, by Fermentation Type, Value (USD Billion), 2026-2033
    • 7.3.1. Microbial Fermentation
    • 7.3.2. Cell Culture-based Fermentation
  • 7.4. Latin America Precision Fermentation CDMO Services Market Outlook, by Country and Subregion, Value (USD Billion), 2026-2033
    • 7.4.1. Brazil Precision Fermentation CDMO Services Market Outlook, by Service Type, 2026-2033
    • 7.4.2. Brazil Precision Fermentation CDMO Services Market Outlook, by End User, 2026-2033
    • 7.4.3. Brazil Precision Fermentation CDMO Services Market Outlook, by Fermentation Type, 2026-2033
    • 7.4.4. Mexico Precision Fermentation CDMO Services Market Outlook, by Service Type, 2026-2033
    • 7.4.5. Mexico Precision Fermentation CDMO Services Market Outlook, by End User, 2026-2033
    • 7.4.6. Mexico Precision Fermentation CDMO Services Market Outlook, by Fermentation Type, 2026-2033

8. Middle East & Africa Precision Fermentation CDMO Services Market Outlook 2026-2033

  • 8.1. Middle East & Africa Precision Fermentation CDMO Services Market Outlook, by Service Type, Value (USD Billion), 2026-2033
    • 8.1.1. Strain Development & Optimization
    • 8.1.2. Process Scale-Up & Manufacturing
    • 8.1.3. Downstream Processing & Purification
    • 8.1.4. Others
  • 8.2. Middle East & Africa Precision Fermentation CDMO Services Market Outlook, by End User, Value (USD Billion), 2026-2033
    • 8.2.1. Alternative Protein Companies
    • 8.2.2. Pharmaceutical & Biotech Companies
    • 8.2.3. Others
  • 8.3. Middle East & Africa Precision Fermentation CDMO Services Market Outlook, by Fermentation Type, Value (USD Billion), 2026-2033
    • 8.3.1. Microbial Fermentation
    • 8.3.2. Cell Culture-based Fermentation

9. Competitive Landscape

  • 9.1. Competitive Positioning and Differentiation
  • 9.2. Company Profiles
    • 9.2.1. Cargill, Incorporated
    • 9.2.2. Ginkgo Bioworks Holdings, Inc.
    • 9.2.3. Lonza Group AG
    • 9.2.4. Archer-Daniels-Midland Company
    • 9.2.5. Amyris, Inc.
    • 9.2.6. Liberation Labs, Inc.
    • 9.2.7. EnginZyme AB
    • 9.2.8. ABEC, Inc.
    • 9.2.9. Fermbox Bio Private Limited
    • 9.2.10. Arzeda Corp.

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations